王佳亮

王佳亮博士毕业于浙江大学，并于中国科学院微生物研究所获得硕士学位。2005年,在美国北卡罗来纳大学(Chapel Hill)获得博士学位后在美国杜克大学(Duke)完成博士后研究。曾任美国田纳西州范德堡大学(Vanderbilt)神经外科系的助理教授，神经肿瘤实验室主任。2020年任圣地亚哥-睿跃生物科技有限公司(Cullgen)转化医学副总裁。
王博士的研究方向主要包括肿瘤的异质化,抗药性,以及创新疗法的开发,在癌症干细胞、抗药性、和新靶点发现等多个领域做出了重要贡献。王博士的实验室曾获美国国家卫生研究所及多个基金会的项目支持,被美国癌症协会(AACR)于2010年评为癌症转化医学的未来领导人。
Jialiang Wang, PhD
Assistant Professor of Neurological Surgery and Cancer Biology
Director, Neurosurgical Oncology Laboratory

Dr. Wang is an assistant professor of Neurological Surgery and directs the Neurosurgical Oncology Laboratory. His research focuses on cancers of the central nervous system. The overarching goal of his research program is to identify and develop innovative and transformative therapeutic strategies to improve treatment for glioma and other human brain cancers. His group aims at signaling pathways that mediate the therapeutic resistance of glioma stem cells, such as the Notch pathway. He is also interested in epigenetic mechanisms that critically regulate glioma biology. He believes that effective treatments for heterogenous diseases, such as glioma, need to be tailored for individual patients according to the molecular profiles of their diseases. In this regard, his laboratory uses a large panel of glioma primary samples to interrogate the links between tumor genotypes and phenotypes.

Education:
Dr. Wang obtained his doctoral degree in biochemistry from the University of North Carolina at Chapel Hill in 2005.

Post-graduate Training:
Dr. Wang received his post-graduate training in brain tumors at Duke University between 2007 and 2010.

https://ww2.mc.vanderbilt.edu/neurosurgery/30181